Prenetics to Participate in the 37th Annual ROTH Conference
Prenetics Global (NASDAQ: PRE), a leading consumer health sciences company, has announced its participation in the 37th Annual ROTH Conference. The event will take place from March 16th to March 18th, 2025, at the Laguna Cliffs Marriott Resort in Dana Point, CA.
CEO Danny Yeung and President of Americas David Vanderveen will be available for one-on-one meetings with investors. Additionally, management will join a panel discussion focused on Longevity and Supplementation on Monday, March 17th at 12:00pm PT. The panel discussion will be accessible via webcast and will be available on Prenetics' investor relations website.
Prenetics Global (NASDAQ: PRE), un'azienda leader nelle scienze della salute dei consumatori, ha annunciato la sua partecipazione alla 37ª Conferenza Annuale ROTH. L'evento si svolgerà dal 16 al 18 marzo 2025, presso il Laguna Cliffs Marriott Resort a Dana Point, CA.
Il CEO Danny Yeung e il Presidente delle Americhe David Vanderveen saranno disponibili per incontri individuali con gli investitori. Inoltre, il management parteciperà a una tavola rotonda incentrata su Longevità e Supplementazione lunedì 17 marzo alle 12:00 PT. La discussione sarà accessibile tramite webcast e sarà disponibile sul sito web delle relazioni con gli investitori di Prenetics.
Prenetics Global (NASDAQ: PRE), una empresa líder en ciencias de la salud del consumidor, ha anunciado su participación en la 37ª Conferencia Anual ROTH. El evento se llevará a cabo del 16 al 18 de marzo de 2025, en el Laguna Cliffs Marriott Resort en Dana Point, CA.
El CEO Danny Yeung y el Presidente de las Américas David Vanderveen estarán disponibles para reuniones individuales con inversores. Además, la dirección participará en una discusión en panel centrada en Longevidad y Suplementación el lunes 17 de marzo a las 12:00 p.m. PT. La discusión del panel será accesible a través de webcast y estará disponible en el sitio web de relaciones con inversores de Prenetics.
프레네틱스 글로벌 (NASDAQ: PRE), 소비자 건강 과학 분야의 선도 기업,이 제37회 연례 ROTH 컨퍼런스에 참여한다고 발표했습니다. 이 행사는 2025년 3월 16일부터 3월 18일까지 캘리포니아 다나 포인트의 라구나 클리프스 메리어트 리조트에서 개최됩니다.
CEO 대니 영과 아메리카스 사장 데이비드 반더빈은 투자자와의 일대일 회의를 위해 자리를 마련할 것입니다. 또한 경영진은 3월 17일 월요일 오후 12시 PT에 장수 및 보충제에 관한 패널 토론에 참여할 것입니다. 패널 토론은 웹캐스트를 통해 접근 가능하며 프레네틱스의 투자자 관계 웹사이트에서 확인할 수 있습니다.
Prenetics Global (NASDAQ: PRE), une entreprise leader dans les sciences de la santé des consommateurs, a annoncé sa participation à la 37e Conférence Annuelle ROTH. L'événement se déroulera du 16 au 18 mars 2025, au Laguna Cliffs Marriott Resort à Dana Point, Californie.
Le PDG Danny Yeung et le Président des Amériques David Vanderveen seront disponibles pour des réunions individuelles avec des investisseurs. De plus, la direction participera à une discussion en panel axée sur la longévité et la supplémentation le lundi 17 mars à 12h00 PT. La discussion en panel sera accessible par webcast et sera disponible sur le site web des relations avec les investisseurs de Prenetics.
Prenetics Global (NASDAQ: PRE), ein führendes Unternehmen im Bereich der Verbraucher-Gesundheitswissenschaften, hat seine Teilnahme an der 37. jährlichen ROTH-Konferenz angekündigt. Die Veranstaltung findet vom 16. bis 18. März 2025 im Laguna Cliffs Marriott Resort in Dana Point, Kalifornien, statt.
CEO Danny Yeung und Präsident der Amerikas David Vanderveen werden für Einzelgespräche mit Investoren zur Verfügung stehen. Darüber hinaus wird das Management an einer Podiumsdiskussion zum Thema Lebensverlängerung und Nahrungsergänzung am Montag, den 17. März um 12:00 Uhr PT teilnehmen. Die Podiumsdiskussion wird über einen Webcast zugänglich sein und auf der Investor-Relations-Website von Prenetics verfügbar sein.
- None.
- None.
CHARLOTTE, N.C., March 11, 2025 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ: PRE), a leading consumer health sciences company, announced today the Company will participate in the 37th Annual ROTH Conference being held Sunday, March 16th to Tuesday, March 18th at the Laguna Cliffs Marriott Resort in Dana Point, CA.
Prenetics’ Chief Executive Officer Danny Yeung and President of Americas David Vanderveen will be available to host one-on-one meetings with investors during the event. In addition, management will participate in a panel discussion on Longevity and Supplementation on Monday, March 17th at 12:00pm PT. Interested parties may access the panel through the webcast link here which will also be posted to Prenetics’ investor relations website here.
To schedule a one-on-one meeting with Prenetics’ management, please contact Investor Relations at PRE@mzgroup.us or your ROTH representative.
About Prenetics
Prenetics (NASDAQ:PRE), a leading health sciences company, is dedicated to advancing consumer and clinical health. Our consumer initiative is led by IM8, a new health and wellness brand, and Europa, one of the largest sports distribution companies in the USA. Our clinical division is led by Insighta, our
Investor Relations Contact:
investors@prenetics.com
PRE@mzgroup.us
Angela Cheung
Investor Relations / Corporate Finance
Prenetics Global Limited
angela.hm.cheung@prenetics.com
FAQ
When and where is Prenetics (PRE) participating in the ROTH Conference 2025?
What panel discussion will Prenetics (PRE) participate in at the ROTH Conference?
How can investors meet with Prenetics (PRE) management at the ROTH Conference?
How can investors access Prenetics' (PRE) panel discussion at the ROTH Conference?
